Severe childhood psoriasis: need for safety and efficacy data on long-term treatment with biologics

Br J Dermatol. 2019 Dec;181(6):1127-1128. doi: 10.1111/bjd.18362. Epub 2019 Aug 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adalimumab
  • Biological Factors
  • Biological Products*
  • Child
  • Double-Blind Method
  • Humans
  • Psoriasis*

Substances

  • Biological Factors
  • Biological Products
  • Adalimumab